Nothing Special   »   [go: up one dir, main page]

Sulpice et al., 1996 - Google Patents

Antagonist effects of Ca2+ and spermine on phosphatidylinositol 4, 5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar …

Sulpice et al., 1996

Document ID
3712423499808797069
Author
Sulpice J
Moreau C
Devaux P
Zachowski A
Giraud F
Publication year
Publication venue
Biochemistry

External Links

Snippet

We have previously suggested the involvement of a Ca2+− phosphatidylinositol 4, 5- bisphosphate (PIP2) complex in the phospholipid transmembrane redistribution triggered by cytosolic Ca2+ in erythrocytes. Indeed, the lipid scrambling was induced by extracellular …
Continue reading at pubs.acs.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin

Similar Documents

Publication Publication Date Title
Bucki et al. Calcium induces phospholipid redistribution and microvesicle release in human erythrocyte membranes by independent pathways
Haque et al. Influence of lipid composition on physical properties and peg-mediated fusion of curved and uncurved model membrane vesicles:“Nature's own” fusogenic lipid bilayer
Ahmed et al. On the origin of sphingolipid/cholesterol-rich detergent-insoluble cell membranes: physiological concentrations of cholesterol and sphingolipid induce formation of a detergent-insoluble, liquid-ordered lipid phase in model membranes
Bevers et al. Changes in membrane phospholipid distribution during platelet activation
Grijalba et al. Ca2+-induced increased lipid packing and domain formation in submitochondrial particles. A possible early step in the mechanism of Ca2+-stimulated generation of reactive oxygen species by the respiratory chain
Goñi et al. Structure and functional properties of diacylglycerols in membranes
Rao et al. Molecular and macromolecular specificity of human plasma phospholipid transfer protein
Wanaski et al. Caveolin scaffolding region and the membrane binding region of SRC form lateral membrane domains
Goñi et al. Phospholipases C and sphingomyelinases: Lipids as substrates and modulators of enzyme activity
Montes et al. Ceramide-Enriched Membrane Domains in Red Blood Cells and the Mechanism of Sphingomyelinase-Induced Hot− Cold Hemolysis
Smirnov et al. The effect of membrane composition on the hemostatic balance
Basáñez et al. Effect of single chain lipids on phospholipase C-promoted vesicle fusion. A test for the stalk hypothesis of membrane fusion
Haque et al. Roles of curvature and hydrophobic interstice energy in fusion: studies of lipid perturbant effects
Bell et al. Relationships between bilayer structure and phospholipase A2 activity: interactions among temperature, diacylglycerol, lysolecithin, palmitic acid, and dipalmitoylphosphatidylcholine
Fry et al. Role of human sperm phospholipase A2 in fertilization: effects of a novel inhibitor of phospholipase A2 activity on membrane perturbations and oocyte penetration
Lehto et al. PI-specific phospholipase C cleavage of a reconstituted GPI-anchored protein: modulation by the lipid bilayer
Ahyayauch et al. Modulation of PI-specific phospholipase C by membrane curvature and molecular order
Koppaka et al. Soluble phospholipids enhance factor Xa-catalyzed prothrombin activation in solution
Wang et al. Cholesterol superlattice modulates the activity of cholesterol oxidase in lipid membranes
Dreger et al. Interactions of the nicotinic acetylcholine receptor transmembrane segments with the lipid bilayer in native receptor-rich membranes
Marchenkova et al. Cytochrome c complexes with cardiolipin monolayer formed under different surface pressure
Sulpice et al. Antagonist effects of Ca2+ and spermine on phosphatidylinositol 4, 5-bisphosphate-mediated transmembrane redistribution of phospholipids in large unilamellar vesicles and in erythrocytes
Falls et al. Role of phosphatidylethanolamine in assembly and function of the factor Ixa− Factor viiia complex on membrane surfaces
Mosior et al. Mechanism of the apparent cooperativity in the interaction of protein kinase C with phosphatidylserine
Wang et al. Cholesterol-dependent phase-demixing in lipid bilayers as a switch for the activity of the phosphoinositide-binding cytoskeletal protein gelsolin